Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets EXMKT - Delayed Quote USD

Abattis Bioceuticals Corp. (ATTBF)

Compare
0.0001
0.0000
(0.00%)
At close: April 15 at 4:00:00 PM EDT
Currency in CAD All numbers in thousands
Breakdown
TTM
Total Revenue
356.8760
Cost of Revenue
115.5400
Gross Profit
241.3360
Operating Expense
4,256.3010
Operating Income
-4,014.9650
Net Non Operating Interest Income Expense
-49.3610
Other Income Expense
1,003.3260
Pretax Income
-3,061
Net Income Common Stockholders
-3,042.0050
Diluted NI Available to Com Stockholders
-3,042.0050
Basic EPS
-0.01
Diluted EPS
-0.01
Basic Average Shares
470,493.0270
Diluted Average Shares
470,493.0270
Total Expenses
4,371.8410
Net Income from Continuing & Discontinued Operation
-3,042.0050
Normalized Income
-3,987.1680
Interest Expense
49.3610
Net Interest Income
-49.3610
EBIT
-3,011.6390
EBITDA
-2,902.6250
Reconciled Cost of Revenue
115.5400
Reconciled Depreciation
109.0140
Net Income from Continuing Operation Net Minority Interest
-3,042.0050
Total Unusual Items Excluding Goodwill
945.1630
Total Unusual Items
945.1630
Normalized EBITDA
-3,847.7880
10/27/57261 - 5/29/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers